Suppr超能文献

15例分子确诊尤因肉瘤病例中CD99和PAX8的免疫组织化学分析

Immunohistochemical Analysis of CD99 and PAX8 in a Series of 15 Molecularly Confirmed Cases of Ewing Sarcoma.

作者信息

Chinchilla-Tábora L M, Ortiz Rodríguez-Parets J, González Morais I, Sayagués J M, Ludeña de la Cruz M D

机构信息

Department of Pathology and IBSAL, University Hospital of Salamanca, Salamanca, Spain.

Department of Pathology, University Hospital of Salamanca, Salamanca, Spain.

出版信息

Sarcoma. 2020 Jun 17;2020:3180798. doi: 10.1155/2020/3180798. eCollection 2020.

Abstract

Ewing sarcomas are an uncommon group of malignant neoplasms. A multidisciplinary approach is highly recommended to reach a correct diagnosis, considering the clinical, radiological, and histopathological aspects. Since in up to 90% of cases, the translocation t (11; 22) (q24; q12) occurs resulting in a chimeric fusion transcript EWSR1-FLI-1. The pathologist has several tools in addition to conventional techniques (hematoxylin and eosin), such as immunohistochemistry, which plays a very important role in the differential diagnosis. We present a series of 15 cases of molecularly confirmed ES, in which we found a sensitivity of 100% for CD99 and 80% for PAX8 by immunohistochemistry. This indicates a high sensitivity; however, it is known that both CD99 and PAX8 are also expressed in other tumours. Therefore, molecular confirmation should be performed in all cases.

摘要

尤因肉瘤是一组罕见的恶性肿瘤。鉴于其临床、放射学和组织病理学方面的特点,强烈建议采用多学科方法来做出正确诊断。由于高达90%的病例会发生t(11;22)(q24;q12)易位,从而产生嵌合融合转录本EWSR1-FLI-1。除了传统技术(苏木精和伊红染色)外,病理学家还有多种工具,如免疫组织化学,其在鉴别诊断中起着非常重要的作用。我们报告了一系列15例经分子确诊的尤因肉瘤病例,通过免疫组织化学我们发现CD99的敏感性为100%,PAX8的敏感性为80%。这表明其具有较高的敏感性;然而,众所周知,CD99和PAX8在其他肿瘤中也有表达。因此,所有病例均应进行分子确诊。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/21d3/7341420/40f63ee1da36/SARCOMA2020-3180798.001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验